Ketamine Completed Phase 2 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02106325Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
NCT01880593Ketamine Plus Lithium in Treatment-Resistant Depression